Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Genetic Diseases, Inborn × Alendronate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1 Osteoporosis 1 Neoplasms 1 Neoplasm Metastasis 1 Genetic Diseases, Inborn 1 Breast Neoplasms 1

Interventions

thymoglobulin 1 ixazomib 1 Transplantation 1 Ketoconazole 1 Cord Blood Stem Cell Transplantation 1 Clinical Trials, Phase II as Topic 1 Circulating Tumor DNA 1 Antilymphocyte Serum 1 Alendronate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00019695 2024-03-04

Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate Cancer

National Cancer Institute (NCI)

Phase 2 Terminated

Neoplasm Metastasis, Neoplasms, Prostatic Neoplasms, Genetic Diseases, Inborn

Data powered by HemOnc (CC BY 4.0) Colophon ⚡